naltrexone has been researched along with Cardiomyopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmadi, SH; Borhani, AA; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Houshmand, G; Riazi, K; Sadeghipour, H; Shafaroodi, H; Tavakoli, S | 1 |
Lishmanov, IuB; Maslov, LN; Naryzhnaia, NV | 1 |
2 other study(ies) available for naltrexone and Cardiomyopathies
Article | Year |
---|---|
Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Bile Ducts; Cardiomyopathies; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Ligation; Male; Myocardial Contraction; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Opioid Peptides; Papillary Muscles; Phenylephrine; Rats; Rats, Sprague-Dawley | 2005 |
[Cardioprotective effects of stimulation of peripheral mu-opiate receptors, and the role of opiatergic mechanisms in the pathogenesis of stress-induced heart damage].
Topics: Animals; Cardiomyopathies; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Immobilization; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Wistar; Receptors, Opioid, mu; Stress, Physiological | 1997 |